Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erythroleukemia: a need for a new definition.

S Park1, F Picard, F Dreyfus

  • 1Service d'Hématologie, Hôpital Cochin, Paris, France.

Leukemia
|July 30, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Kernel-based testing for single-cell differential analysis.

Genome biology·2024
Same author

[Digital transformation of perioperative nurse-coordinated protocols in renal surgery for enhanced recovery and outpatient surgery using UroConnect® application].

Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie·2022
Same author

Remote patient monitoring for chronic heart failure in France: When an innovative funding program (ETAPES) meets an innovative solution (Satelia® Cardio).

Digital health·2022
Same author

Dermatologic manifestations in paediatric neurofibromatosis type 2: a cross sectional descriptive multicentric study.

Orphanet journal of rare diseases·2022
Same author

Right adrenalectomy by laparoscopic lateral transperitoneal approach.

Journal of visceral surgery·2021
Same author

Prediction of the intramuscular connective tissue components of fresh and freeze-dried samples by near infrared spectroscopy.

Meat science·2021

The WHO classification redefines acute myeloid leukemia, merging RAEB-t and AML, and clarifies erythroleukemia subtypes. This enhances understanding of de novo versus secondary erythroleukemias and prognostic factors.

Area of Science:

  • Hematology
  • Oncology
  • Pathology

Background:

  • The previous FAB classification had a distinct boundary for RAEB-t (20% blasts) and AML (30% blasts).
  • Erythroleukemia definitions and classifications have evolved, necessitating a review of FAB AML6, RAEB-t, and AML6 variant.
  • Understanding the distinction between secondary erythroleukemias and RAEB-t is crucial for accurate diagnosis and treatment.

Purpose of the Study:

  • To review and clarify the definitions of erythroleukemia.
  • To discuss the relationship between FAB AML6, RAEB-t, and AML6 variant in light of the new WHO classification.
  • To determine if secondary erythroleukemias share characteristics with RAEB-t regarding survival, karyotype, and cytology.

Main Methods:

  • Review of existing literature and classification systems (FAB and WHO).

Related Experiment Videos

  • Comparative analysis of clinical, cytogenetic, and cytologic features of different erythroleukemia subtypes.
  • Discussion of the implications of the WHO classification on the diagnosis and categorization of erythroleukemias.

    • Main Results:

    • The WHO classification eliminates the blast percentage threshold difference between RAEB-t and AML.
    • 'AML6 variant' with pure erythroid proliferation is proposed as true de novo erythroleukemia.
    • Current FAB AML6 cases are likely to be reclassified under WHO categories such as multilineage dysplasia, therapy-related leukemia, or acute erythroid leukemia.

    Conclusions:

    • The WHO classification provides a more refined approach to diagnosing and classifying erythroleukemias.
    • Distinguishing between de novo and secondary erythroleukemias is critical and aided by the new classification.
    • Clinical and cytogenetic prognostic factors are emphasized in the WHO system for better patient management.